Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Nicole Gonzales

Concepts (296)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Hemorrhage
26
2023
96
4.630
 Why?
Stroke
36
2023
1019
3.480
 Why?
Tissue Plasminogen Activator
22
2023
225
2.050
 Why?
Brain Ischemia
18
2023
299
1.750
 Why?
Fibrinolytic Agents
16
2023
233
1.550
 Why?
Thrombolytic Therapy
13
2023
117
1.380
 Why?
Hematoma
6
2015
49
0.860
 Why?
Ischemic Attack, Transient
1
2023
62
0.830
 Why?
Neurology
3
2020
84
0.800
 Why?
Endarterectomy, Carotid
4
2015
42
0.790
 Why?
Platelet Aggregation Inhibitors
3
2022
400
0.740
 Why?
Carotid Stenosis
4
2014
79
0.730
 Why?
Women
1
2020
51
0.700
 Why?
Decompressive Craniectomy
1
2019
8
0.670
 Why?
Time-to-Treatment
2
2021
147
0.660
 Why?
Medicine
1
2020
102
0.640
 Why?
Stents
5
2015
475
0.620
 Why?
Matrix Metalloproteinases
1
2019
89
0.610
 Why?
Percutaneous Coronary Intervention
1
2022
444
0.580
 Why?
Attention
1
2020
394
0.560
 Why?
Angioplasty
2
2014
40
0.550
 Why?
Brain Injuries
1
2020
452
0.490
 Why?
Aged
37
2023
19094
0.490
 Why?
Cerebral Revascularization
1
2014
15
0.480
 Why?
Treatment Outcome
28
2023
9089
0.470
 Why?
Middle Aged
39
2023
26757
0.460
 Why?
Hypertension
3
2016
1059
0.420
 Why?
Humans
63
2023
114756
0.410
 Why?
Thiazolidinediones
2
2012
142
0.390
 Why?
Health Education
4
2023
324
0.350
 Why?
Female
43
2023
59507
0.340
 Why?
Mobile Health Units
2
2021
18
0.340
 Why?
Disability Evaluation
3
2021
271
0.330
 Why?
Clinical Trials as Topic
6
2023
935
0.330
 Why?
Male
45
2023
55579
0.330
 Why?
Prospective Studies
13
2023
6217
0.310
 Why?
Emergency Medical Services
4
2023
587
0.300
 Why?
Aged, 80 and over
18
2023
6350
0.300
 Why?
Schools
2
2007
399
0.280
 Why?
Awareness
1
2007
93
0.260
 Why?
Risk Factors
9
2022
8627
0.260
 Why?
Time Factors
11
2019
6124
0.260
 Why?
Demyelinating Autoimmune Diseases, CNS
1
2005
2
0.260
 Why?
Anticoagulants
3
2019
547
0.250
 Why?
Paraneoplastic Syndromes, Nervous System
1
2005
9
0.250
 Why?
Encephalomyelitis, Acute Disseminated
1
2005
13
0.250
 Why?
Hypoglycemic Agents
1
2012
1009
0.230
 Why?
Postoperative Complications
1
2014
2127
0.230
 Why?
Pilot Projects
5
2023
1370
0.220
 Why?
American Heart Association
2
2023
264
0.220
 Why?
Antihypertensive Agents
3
2016
429
0.220
 Why?
Pyramidal Tracts
1
2023
20
0.220
 Why?
Encephalitis, Herpes Simplex
1
2003
19
0.220
 Why?
Skin Diseases, Vesiculobullous
1
2003
17
0.220
 Why?
Herpesvirus 2, Human
1
2003
27
0.220
 Why?
Diffusion Tensor Imaging
1
2023
62
0.210
 Why?
Cytochrome P-450 CYP2C19
1
2022
24
0.210
 Why?
Databases, Factual
3
2019
1128
0.210
 Why?
Ambulances
2
2021
50
0.210
 Why?
Heterozygote
1
2022
251
0.200
 Why?
Adult
17
2023
30548
0.200
 Why?
Retrospective Studies
15
2019
12515
0.190
 Why?
Neuroprotective Agents
2
2015
105
0.190
 Why?
PPAR gamma
3
2014
182
0.190
 Why?
Health Promotion
2
2007
686
0.190
 Why?
Cerebral Ventricles
2
2013
47
0.190
 Why?
Anxiety Disorders
1
2023
303
0.180
 Why?
Aspirin
1
2022
324
0.170
 Why?
United States
9
2023
12176
0.170
 Why?
Predictive Value of Tests
4
2019
1796
0.170
 Why?
Overweight
1
2023
471
0.170
 Why?
Factor VIIa
2
2011
36
0.170
 Why?
Schools, Medical
1
2020
120
0.170
 Why?
Pipecolic Acids
2
2012
23
0.170
 Why?
Recovery of Function
3
2019
572
0.160
 Why?
Adenocarcinoma
1
2005
801
0.160
 Why?
Disease Progression
3
2013
2387
0.160
 Why?
Glasgow Coma Scale
1
2019
143
0.160
 Why?
Health Services Needs and Demand
1
2020
244
0.150
 Why?
Propensity Score
1
2019
224
0.150
 Why?
Edema
1
2019
118
0.150
 Why?
Isoenzymes
1
2019
285
0.150
 Why?
Dose-Response Relationship, Drug
4
2012
1846
0.150
 Why?
NF-E2-Related Factor 2
2
2015
71
0.150
 Why?
Mexican Americans
2
2009
102
0.150
 Why?
Genotype
1
2022
1774
0.150
 Why?
Sex Factors
3
2019
1717
0.150
 Why?
Anxiety
1
2023
842
0.140
 Why?
Hospital Mortality
2
2019
776
0.140
 Why?
Decision Making
1
2023
781
0.140
 Why?
Injury Severity Score
1
2019
456
0.140
 Why?
Tomography, X-Ray Computed
4
2021
2269
0.140
 Why?
Platelet Transfusion
1
2017
64
0.140
 Why?
Ultrasonography, Doppler, Transcranial
3
2013
42
0.130
 Why?
Prognosis
4
2019
3334
0.130
 Why?
Microglia
2
2008
202
0.130
 Why?
Texas
4
2013
188
0.130
 Why?
Quality of Health Care
1
2020
573
0.130
 Why?
Fumarates
1
2015
10
0.130
 Why?
Blood Pressure
3
2011
1530
0.120
 Why?
Antithrombins
2
2013
49
0.120
 Why?
Anti-Inflammatory Agents
2
2011
450
0.120
 Why?
Pneumonia, Viral
1
2020
340
0.120
 Why?
Recombinant Proteins
4
2011
1233
0.120
 Why?
Coronavirus Infections
1
2020
332
0.120
 Why?
Retinoid X Receptors
1
2014
39
0.120
 Why?
Intraoperative Complications
1
2015
121
0.120
 Why?
Perioperative Care
1
2015
126
0.120
 Why?
Cohort Studies
7
2022
4901
0.120
 Why?
Cerebral Infarction
1
2014
39
0.110
 Why?
Follow-Up Studies
4
2017
4420
0.110
 Why?
Neutrophil Infiltration
1
2014
94
0.110
 Why?
Single-Blind Method
1
2014
258
0.110
 Why?
Biomarkers
2
2019
3416
0.110
 Why?
Odds Ratio
3
2021
954
0.110
 Why?
Delivery of Health Care
1
2020
833
0.110
 Why?
Exercise
1
2023
1644
0.110
 Why?
Sulfonamides
3
2012
445
0.110
 Why?
Genetic Predisposition to Disease
1
2021
2099
0.110
 Why?
Quality Control
1
2013
144
0.110
 Why?
Telemedicine
2
2020
663
0.110
 Why?
Severity of Illness Index
7
2021
2539
0.100
 Why?
Lung Neoplasms
1
2005
2199
0.100
 Why?
Medical Records
1
2013
153
0.100
 Why?
Healthcare Disparities
1
2017
479
0.100
 Why?
Neurosurgical Procedures
1
2013
152
0.100
 Why?
Carotid Artery, Internal
1
2011
36
0.100
 Why?
Cyclooxygenase 2 Inhibitors
1
2011
20
0.100
 Why?
Celecoxib
1
2011
38
0.100
 Why?
Cerebral Amyloid Angiopathy
1
2011
9
0.100
 Why?
Collagen Type IV
1
2011
22
0.090
 Why?
Nervous System Diseases
1
2014
252
0.090
 Why?
History, 20th Century
1
2012
265
0.090
 Why?
Brain Edema
1
2011
60
0.090
 Why?
Carotid Arteries
1
2012
180
0.090
 Why?
Universities
1
2013
339
0.090
 Why?
NF-kappa B
1
2014
636
0.090
 Why?
Nephrology
1
2011
48
0.090
 Why?
Injections, Intra-Arterial
4
2013
25
0.090
 Why?
Risk Assessment
1
2019
2973
0.090
 Why?
Double-Blind Method
2
2012
1662
0.090
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2009
22
0.090
 Why?
Treatment Failure
2
2014
332
0.080
 Why?
Research Design
2
2013
931
0.080
 Why?
Heparin
1
2011
222
0.080
 Why?
Endovascular Procedures
1
2013
268
0.080
 Why?
Venous Thrombosis
1
2011
140
0.080
 Why?
Resuscitation Orders
1
2009
45
0.080
 Why?
Registries
2
2014
1759
0.080
 Why?
Health Care Surveys
1
2011
539
0.080
 Why?
Hand Transplantation
1
2008
9
0.080
 Why?
Intracranial Thrombosis
1
2008
17
0.080
 Why?
Caffeine
1
2009
57
0.080
 Why?
Quality Improvement
1
2016
951
0.080
 Why?
Neutrophils
1
2014
1163
0.080
 Why?
Surveys and Questionnaires
1
2020
4625
0.080
 Why?
Pyrazoles
1
2011
364
0.080
 Why?
Embolism
1
2008
43
0.080
 Why?
Hypothermia, Induced
1
2009
66
0.080
 Why?
Hand Injuries
1
2008
33
0.080
 Why?
Practice Patterns, Physicians'
2
2017
1178
0.070
 Why?
Renal Dialysis
1
2011
369
0.070
 Why?
Adolescent
7
2014
17808
0.070
 Why?
Organ Transplantation
1
2008
159
0.070
 Why?
Kidney Failure, Chronic
1
2011
487
0.060
 Why?
Teaching
1
2007
214
0.060
 Why?
Emergency Service, Hospital
1
2016
1812
0.060
 Why?
Nerve Fibers, Myelinated
1
2005
41
0.060
 Why?
Methylprednisolone
1
2005
82
0.060
 Why?
Emergency Treatment
1
2006
113
0.060
 Why?
Diffusion Magnetic Resonance Imaging
1
2005
83
0.060
 Why?
Case-Control Studies
3
2021
3005
0.060
 Why?
Heart Diseases
1
2008
330
0.060
 Why?
Paralysis
1
2005
66
0.060
 Why?
Brain Stem
1
2005
101
0.060
 Why?
Ethanol
1
2009
548
0.060
 Why?
Muscle Weakness
1
2005
80
0.060
 Why?
Program Development
1
2007
342
0.060
 Why?
Injections, Intravenous
3
2011
201
0.060
 Why?
Fatal Outcome
1
2005
284
0.060
 Why?
Phagocytosis
3
2014
350
0.060
 Why?
Administration, Intravenous
2
2017
124
0.060
 Why?
Peptides
1
2009
848
0.060
 Why?
Hemorrhage
2
2023
618
0.060
 Why?
Chi-Square Distribution
2
2017
494
0.060
 Why?
Meningitis, Aseptic
1
2003
15
0.050
 Why?
Growth and Development
1
2023
6
0.050
 Why?
Spinal Cord
1
2005
347
0.050
 Why?
Students
1
2007
501
0.050
 Why?
Principal Component Analysis
1
2023
176
0.050
 Why?
Brain
1
2014
2374
0.050
 Why?
Headache
1
2003
132
0.050
 Why?
Certification
1
2023
89
0.050
 Why?
Acute Disease
3
2011
912
0.050
 Why?
Catalase
2
2014
117
0.050
 Why?
Macrophages
1
2008
1261
0.050
 Why?
Respiratory Insufficiency
1
2005
291
0.050
 Why?
Partial Thromboplastin Time
2
2012
51
0.050
 Why?
Practice Guidelines as Topic
3
2017
1393
0.050
 Why?
Reperfusion
2
2013
36
0.050
 Why?
DNA, Viral
1
2003
350
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
928
0.050
 Why?
Caregivers
1
2007
717
0.050
 Why?
Guideline Adherence
2
2017
490
0.050
 Why?
Young Adult
2
2014
10463
0.040
 Why?
Hospital Bed Capacity
1
2020
21
0.040
 Why?
Magnetic Resonance Imaging
3
2023
3039
0.040
 Why?
Health Care Rationing
1
2020
45
0.040
 Why?
Ethics, Medical
1
2020
70
0.040
 Why?
Rats, Sprague-Dawley
2
2015
2209
0.040
 Why?
Kaplan-Meier Estimate
2
2012
815
0.040
 Why?
Health Resources
1
2020
122
0.040
 Why?
Logistic Models
2
2017
1843
0.040
 Why?
Combined Modality Therapy
2
2013
1122
0.040
 Why?
Hospitals
1
2023
580
0.040
 Why?
Arginine
2
2012
236
0.040
 Why?
CD36 Antigens
2
2008
37
0.040
 Why?
Autoantibodies
1
2005
1350
0.040
 Why?
Ventriculostomy
1
2017
17
0.040
 Why?
Betacoronavirus
1
2020
252
0.040
 Why?
Disease Models, Animal
3
2014
3542
0.030
 Why?
Longitudinal Studies
1
2023
2386
0.030
 Why?
Rats
2
2015
4943
0.030
 Why?
Drug Therapy, Combination
2
2012
954
0.030
 Why?
Body Mass Index
1
2023
1958
0.030
 Why?
Statistics, Nonparametric
1
2017
386
0.030
 Why?
Intensive Care Units
1
2020
618
0.030
 Why?
Thrombocytopenia
1
2017
177
0.030
 Why?
Dimethyl Fumarate
1
2015
10
0.030
 Why?
Neuroimmunomodulation
1
2014
70
0.030
 Why?
Biomedical Research
1
2020
585
0.030
 Why?
Animals
5
2015
31761
0.030
 Why?
Health Services Accessibility
1
2020
763
0.030
 Why?
Perfusion Imaging
1
2014
51
0.030
 Why?
Multivariate Analysis
1
2017
1435
0.030
 Why?
Erythrocytes
2
2008
591
0.030
 Why?
Sex Distribution
1
2014
335
0.030
 Why?
Tomography Scanners, X-Ray Computed
1
2012
17
0.030
 Why?
Quality of Life
1
2023
2358
0.030
 Why?
Mice, Inbred C57BL
2
2015
4710
0.030
 Why?
Pandemics
1
2020
1319
0.020
 Why?
Cerebral Veins
1
2012
15
0.020
 Why?
Cerebral Arteries
1
2012
55
0.020
 Why?
Obesity
1
2023
2513
0.020
 Why?
Plasminogen Activators
1
2011
7
0.020
 Why?
Length of Stay
1
2015
949
0.020
 Why?
Heparin, Low-Molecular-Weight
1
2011
27
0.020
 Why?
Radiography
1
2013
811
0.020
 Why?
Mice
3
2015
14916
0.020
 Why?
Magnetic Resonance Angiography
1
2012
219
0.020
 Why?
Analysis of Variance
1
2013
1226
0.020
 Why?
Life Support Care
1
2009
28
0.020
 Why?
Buspirone
1
2009
4
0.020
 Why?
Shivering
1
2009
4
0.020
 Why?
Meperidine
1
2009
4
0.020
 Why?
Adjuvants, Anesthesia
1
2009
8
0.020
 Why?
Microcirculation
1
2009
135
0.020
 Why?
Academic Medical Centers
1
2011
413
0.020
 Why?
Microspheres
1
2009
123
0.020
 Why?
Mice, Knockout
1
2015
2582
0.020
 Why?
Brain Damage, Chronic
1
2008
19
0.020
 Why?
Anti-Anxiety Agents
1
2009
42
0.020
 Why?
Infusions, Intra-Arterial
1
2008
46
0.020
 Why?
Cerebral Angiography
1
2008
109
0.020
 Why?
Deep Brain Stimulation
1
2009
72
0.020
 Why?
Drug Combinations
1
2009
286
0.020
 Why?
Blood Flow Velocity
1
2009
387
0.020
 Why?
Infusions, Intravenous
1
2008
372
0.020
 Why?
Behavior
1
2008
92
0.020
 Why?
Cultural Competency
1
2008
72
0.020
 Why?
Enzyme Activators
1
2007
6
0.020
 Why?
Prostaglandin D2
1
2007
21
0.020
 Why?
Regression Analysis
1
2009
946
0.020
 Why?
Urokinase-Type Plasminogen Activator
1
2006
28
0.020
 Why?
Nitric Oxide Synthase Type II
1
2007
157
0.020
 Why?
Graft Survival
1
2008
452
0.020
 Why?
Reproducibility of Results
1
2013
2763
0.020
 Why?
Hydrogen Peroxide
1
2007
287
0.020
 Why?
Urban Population
1
2008
398
0.020
 Why?
Recurrence
1
2008
936
0.020
 Why?
Graft Rejection
1
2008
516
0.020
 Why?
Animals, Newborn
1
2007
777
0.020
 Why?
Self Efficacy
1
2008
355
0.010
 Why?
Atrial Fibrillation
1
2008
324
0.010
 Why?
Myocardial Infarction
1
2011
927
0.010
 Why?
Recombinant Fusion Proteins
1
2006
617
0.010
 Why?
Program Evaluation
1
2007
822
0.010
 Why?
Age Factors
1
2009
2890
0.010
 Why?
Curriculum
1
2007
825
0.010
 Why?
Apoptosis
1
2008
2369
0.010
 Why?
Parents
1
2007
1190
0.010
 Why?
Cells, Cultured
1
2007
3890
0.010
 Why?
Cytokines
1
2007
1843
0.010
 Why?
Health Knowledge, Attitudes, Practice
1
2007
1183
0.010
 Why?
Neurons
1
2007
1281
0.010
 Why?
Child
1
2007
18352
0.000
 Why?
Gonzales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (296) concept(s)
_
Co-Authors Expand Description
See all (3) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)